RHUMBLINE ADVISERS - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$419,000
+6.9%
286,957
+3.9%
0.00%0.0%
Q4 2016$392,000
-13.3%
276,171
+7.0%
0.00%0.0%
Q3 2016$452,000
+4.4%
258,089
+1.9%
0.00%0.0%
Q2 2016$433,000
-11.6%
253,279
+1.9%
0.00%
-50.0%
Q1 2016$490,000
+4.3%
248,649
+0.5%
0.00%0.0%
Q4 2015$470,000
+8.8%
247,399
+9.3%
0.00%
+100.0%
Q3 2015$432,000
-59.2%
226,424
-0.8%
0.00%
-66.7%
Q2 2015$1,059,000
-3.1%
228,251
-8.8%
0.00%0.0%
Q1 2015$1,093,000
+58.4%
250,151
+25.7%
0.00%
+50.0%
Q4 2014$690,000
-19.3%
198,951
-2.5%
0.00%
-33.3%
Q3 2014$855,000
-28.6%
204,137
-0.0%
0.00%
-25.0%
Q2 2014$1,197,000
-13.3%
204,237
-6.8%
0.00%0.0%
Q1 2014$1,381,000
+4.9%
219,249
-2.5%
0.00%0.0%
Q4 2013$1,316,000
+4.9%
224,969
-5.5%
0.00%0.0%
Q3 2013$1,255,000
-32.1%
238,099
-0.8%
0.00%
-33.3%
Q2 2013$1,849,000240,0850.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 9,750,000$18,623,0001.60%
DAFNA Capital Management LLC 381,600$729,0000.72%
SENZAR ASSET MANAGEMENT, LLC 1,766,991$3,374,953,0000.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,640,877$8,864,0000.34%
Lyons Wealth Management, LLC. 56,665$110,0000.14%
FEDERATED HERMES, INC. 5,648,920$10,789,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 33,909,459$64,767,0000.02%
Cubist Systematic Strategies, LLC 185,166$354,0000.02%
GAM Holding AG 523,164$997,0000.02%
STEVENS CAPITAL MANAGEMENT LP 191,236$365,0000.02%
View complete list of ARENA PHARMACEUTICALS INC shareholders